Real-world study of efficacy, risk management and reasons...

PLoS ONE 2019 / 5 Vol. 14; Iss. 5

Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia

Evdoshenko, Evgeniy, Stepanova, Alexandra, Shumilina, Maria, Davydovskaya, Maria, Khachanova, Natalia, Neofidov, Nikolay, Kalinin, Ivan, Popova, Ekaterina, Dubchenko, Ekaterina, Pozhidaeva, Natalia, V
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0217303
Date:
May, 2019
File:
PDF, 685 KB
english, 2019
Conversion to is in progress
Conversion to is failed